Title:Protective Effects of Liriodendrin on Myocardial Infarction-Induced
Fibrosis in Rats via the PI3K/Akt Autophagy Pathway: A Network
Pharmacology Study
Volume: 27
Issue: 11
Author(s): Ping Zhang, Xuanming Liu, Xin Yu, Yuzhen Zhuo, Dihua Li, Lei Yang*Yanmin Lu*
Affiliation:
- Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Tianjin Nankai Hospital, Tianjin, 300100, China
- Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Tianjin Nankai Hospital, Tianjin, 300100, China
Keywords:
Autophagy, liriodendrin, myocardial fibrosis, network pharmacology, PI3K-Akt signaling pathway, myocardial infarction (MI).
Abstract:
Background: Liriodendrin (LIR) has been reported to improve cardiac function in rats
following myocardial infarction. However, its role and mechanism in reparative myocardial fibrosis
remain unclear.
Methods: In this study, a rat model of myocardial fibrosis was established via left anterior descending
artery ligation and randomly divided into three groups (n = 6 per group): sham-operated,
myocardial infarction, and LIR intervention (100 mg/kg/day) groups. The pharmacological effects
of LIR were assessed using echocardiography, hematoxylin, and eosin (H&E) staining, and Masson
staining. Network pharmacology and bioinformatics were utilized to identify potential mechanisms
of LIR, which were further validated via western blot analysis.
Results: Our findings demonstrated that LIR improved cardiac function, histology scores, and col
lagen volume fraction. Moreover, LIR downregulated the expression of Beclin-1, LC3-II/LC3-I
while upregulating the expression of p62, indicating LIR-inhibited autophagy in the heart after
myocardial infarction. Further analysis revealed that the PI3K/Akt signaling pathway was significantly
enriched and validated by western blot. This analysis suggested that the ratios of p-
PI3K/PI3K, p-Akt/Akt, and p-mTOR/mTOR were significantly increased.
Conclusion: LIR may attenuate myocardial infarction-induced fibrosis in rats by inhibiting excessive
myocardial autophagy, with the potential mechanism involving the activation of the
PI3K/Akt/mTOR pathway.